EMCC European Monitoring Centre on Change



Geographic Location

Country: France


Sector: Manufacturing
Manufacture of pharmaceuticals, medicinal chemical and botanical products
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
Number Employed: 13000
Group: Aventis

Employment Effects

Announcement Date: 08-12-2003
Planned Job Reductions min: 1800
Planned Job Reductions max: 1800
Type of Restructuring: Internal restructuring
Employment Effect Start: 01-01-2004

Additional Information

Aventis, the Franco-German pharmaceutical group, could close half of its production sites worldwide. As of 2004, measures will be taken in order to stimulate company growth, cutting costs by 500 million euros per year till 2006. In the framework of this restructuring plan, 1.800 jobs could be affected in France, out of the 13.000 people presently employed by the company. Slowing of sales in the US market and changing health policies in France and Germany explain the financial difficulties the group is facing.